Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019

Overview of attention for article published in JAMA Network Open, May 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 120 news outlets
blogs: 6 blogs

policy: 1 policy source
twitter: 41 tweeters

Citations

dimensions_citation: 39 Dimensions

Readers on

mendeley: 29 Mendeley

Summary News Blogs Policy documents Twitter Dimensions citations

So far, Dimensions has found 39 publications that cite this research output.

39

The most recent citing publications are shown below. View all 39 publications that cite this research output on Dimensions.

Getting Jab or Regular Test: Observations from an Impulsive Epidemic COVID-19 Model

Article in Bulletin of Mathematical Biology (September 2023)

Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients

Article in The Lancet Infectious Diseases (September 2023)

Multiplex PCR assay to detect nasopharyngeal viruses in immunocompromised patients with acute respiratory failure.

Article in CHEST Journal (August 2023)